Kamal Amin, Senior Clinical Supply Manager, Fujifilm Kyowa Kirin Biologics, United Kingdom
Nir Arbel, Co-Founder And Chief Executive Officer, Carmentix, Singapore
Ignacio Asial, Founder & CEO, DOTBIO, Singapore
Raphael Aswin Susilo, Vice President - Research And Development, Regulatory And Medical Affairs, Soho Global Health, Indonesia
Shailendra Bajpai, Regional Medical Director, Sanofi-Aventis Singapore Pte Ltd, Singapore
Raghu Bathina, Founder, Future World Studios, India
Lynne Baxter, Team Leader Clinical Study Research, Danone Nutricia Research, Singapore
Mario Bertazzoli, Director, Group Head Of Drug Safety, Helsinn SA, Switzerland
Rhenu Bhuller, Partner, Frost & Sullivan, Singapore
Vivian Bian, Chief Operating Officer, BeiGene, China
Jerome Boyd-Kirkup, Chief Scientific Officer, Hummingbird Bioscience, Singapore
Howard Califano, Director, SMART Innovation Centre, Singapore-MIT Alliance for Research and Technology, Singapore
Sean Wuxiong Cao, Managing Director, C Bridge Capital, United States
Arani Chatterjee, Senior Vice President, Clinical Research, Aurobindo Pharma, India
Adam Chee, Founder & Chief Advocacy Officer, BinaryHealthCare, Singapore
Yi-Chun Maria Chen, Director Of Business Development, Immunwork Inc., Taiwan
Younggyu Cho, Chief Technology Officer, Y Biologics, Republic Of Korea
Abraham Cinta, Chief Executive Officer, ARC Capital, Singapore
Alexandre Civiere, Project Manager, CellProthera Pte Ltd, Singapore
Matt Cooper, Business Development And Research Director, NIHR Clinical Research Network, United Kingdom
Michael Cutler, Chief Data Officer ASPAC, KPMG Lighthouse, Singapore
Jeff Dao, Operating Officer and Business Development Officer, HighTide Therapeutics, United States
Harish Dave, Chief Medical Officer, AUM Biosciences, Singapore
Anthony Desir, Director, Moexa, Hong Kong
Vishal Doshi, Chief Executive Officer, AUM Biosciences, Singapore
Xin Du, Senior Vice President And Head Of Global Regulatory Affairs, Adlai Nortye Biopharma, China
Sinclair Dunlop, Managing Partner, Epidarex Capital, United Kingdom
Nick Ede, Chief Technology Officer, Imugene Ltd, Australia
Nahlah Elkudssiah Ismail, Deputy Dean Academic & Operations & Professor Dr. in Clinical Pharmaceutics, Faculty of Pharmacy, Universiti MAHSA, Malaysia
Enver Erkan, Country Manager, Pfizer, Singapore
Carl Firth, Chief Executive Officer, ASLAN Pharmaceuticals, Singapore
James. Garner, Chief Executive Officer and Managing Director, Kazia Therapeutics Limited, Australia
Mario Gattino, Chief Executive Officer, Respiri, Australia
Anand Gautam, Senior Director And Head, External Science And Innovation, Anz And Sea, Pfizer, Australia
Andrew Gebbie, Business Consultant, Medidata, United Kingdom
Wei Jiang Goh, Co-Founder & CEO, Craft Health, Singapore
Shridhar Gopal, Head Business Development, International, JEM&A, AbbVie, United States
Ogan Gurel, Chief Scientific Officer, FRT, Chief Marketing Officer, Eidware/SoundMind and Visiting Professor, D.G.I.S.T., Republic Of Korea
Mayank Gurnani, Associate Director, Industry Liaison Office, National University of Singapore, Singapore
Sungjae Ha, Chief Technology Officer, Femtobiomed, Republic Of Korea
Jeonghoon Han, Vice President, Chief Development And Technology Officer, Eutilex Ltd, Republic Of Korea
Vicky Han, Senior Director, Regulatory Policy Group Lead For Asia Pacific, Janssen Pharmaceuticals, Singapore
Chris Hardesty, Director, KPMG Singapore Life Sciences, Singapore
Carrie Hillyard, Chairman, FitGenes, Australia
Nomura Hironoshin, Pharmaceuticals, Biotech, Otc And Small Companies, Mizuho Securities, Japan
Chervee Ho, Director Key Account Management, Asia Pacific, Vetter Pharma International GmbH, Singapore
Dean Ho, Co-Founder, KYAN Therapeutics, United States
Allen Huang, VP, Chaperone Investment, Taiwan
Ian Huen, Chief Executive Officer, Aptorum Group, Hong Kong
Yuliana Indriati, President Director, Pt. Kalbe Genexine Biologics, Indonesia
Henry Ines, Chief Executive Officer, Shivom.io, United States
Mrunalini Jagtap, Data Management Lead, SICS, A*STAR, Singapore
Nitin Jain, Vice President, Asia-Pacific, ANCILLARE, LP, Singapore
Anand Jha, Managing Director, Ansea Consultants Pte Ltd, Singapore
Handsome Ji, Apac Publishing Lead, Pfizer China, China
Jamila Joseph, Senior Vice President - Innovative Technologies & Clinical Research, Reliance Life Sciences, India
Jeong Beom Kim, CEO, SuPine Therapeutics, Republic Of Korea
Seokjoong Kim, Director And Head Of Business Development, Toolgen, Republic Of Korea
Andreas Koester, Global Head & VP, Janssen Clinical Innovation, Johnson & Johnson, United States
Alexander Kort, Senior Vice President Corporate Development, Themis Bioscience GmbH, Austria
Prabhuram Krishnan, South Asia Medical Director, Ipsen Pharma, Malaysia
Amit Kumar, Co-Founder & CEO, Biopsin Pte Ltd, Singapore
Aaron Kurzak, Head of Product, Alodokter, Indonesia
David Lane, Chief Scientist, Agency for Science, Technology and Research (A*STAR), Singapore
Antonio Lee, Chief Executive Officer And Managing Director, MEDIPOST America, Republic Of Korea
Don Lee, Manager, SCM Lifescience, Republic Of Korea
Victor Li, Chief Executive Officer, Lion TCR, Singapore
Mai Jing Liao, Chief Business Officer, Harbour Biomed, China
Maggie Lim, Director Qa, GSK Pte Ltd, Singapore
Edmund Lim, Co-Founder, We CARE Journey, Malaysia
Xiangqian Lin, Managing Partner, Esco Ventures, Singapore
Xichen Lin, Director Of Innovation Sourcing, Novo Nordisk, China
Liping Liu, Chief Executive Officer And Chief Scientific Officer, Shenzhen HighTide Biopharmaceutical Ltd., China
Stephanie Liu, Medical, Regulatory & Clinical Quality Assurance (MRC QA) Lead, Lundbeck Singapore, Singapore
Finny Liu, Apac Regional Regulatory Policy Lead, Roche, Singapore
Keita Maeda, Deputy Director of Bio-Industry Division, Ministry of Economy Trade and Industry Japan, Japan
Josemund Menezes, Medical Affairs Director, Tessa Therapeutics, Singapore
Joseph Mocanu, Managing Director, Verge Capital Management, Singapore
Aung Myo, Vice President, Clinical Development, Tessa Therapeutics, Singapore
Sabrina Ng, Chief Financial Officer, Hummingbird Bioscience, Singapore
Damian O'Connell, CEO Experimental Drug Development Centre, A Star - Agency For Science Technology And Research, Singapore
Yongho Oh, Regional Clinical Project Manager And Iss Project Manager, Jpac And China, Sanofi, Singapore
Jason Orbaugh, Director of Business Development, Path Therapeutics, Inc., Canada
Ying Pan, Director, Translational Science, CStone, China
Evelyn Pang, Manager, L.E.K. Consulting, Singapore
Anil Pareek, President, Medical Affairs And Clinical Research, Ipca Laboratories Ltd, India
Chongdeok Park, Chief Development Officer, Kolon Pharmaceuticals, Republic Of Korea
Steve Pask, Head of Business Development AUS/NZ, Novartis, Australia
John Patava, Chief Operating Officer, AUM Biosciences, Singapore
Ashish Patel, Head Of Research, Investment Manager, Mercia Technologies, United Kingdom
Phusit Prakongsai, Ministry of Public Health Thailand, Thailand
Aparajeeta Priyadarasini, Solution Consultant, Medidata Solutions, Singapore
Gang Qin, Chief Executive Officer, GeneQuantum Healthcare Suzhou, China
Mahboob Rahman, President & Chief Medical Officier, Glenmark Pharmaceuticals Ltd, United States
Gopal Rao, Global Business Development And Services Outsourcing, Biotech Division Lupin Ltd, India
Byung-Geon Rhee, Chief Executive Officer, SCM Lifescience, Republic Of Korea
Edward Rosen, Leader, Glendevon Life Sciences LLC & Executive in Residence, Columbia Technology Ventures, United States
Ross Rothmeier, Vice President, Tech Solutions, Medidata Solutions, United States
Bechara Saab, Chief Executive Officer and Chief Scientist, Mobio Interactive, China
Dr Sushant Sahastrabuddhe, Director, Enteric Fever, International Vaccine Institute, Republic Of Korea
Giridhar Sathiamoorthy, Director, Business Operations & Project Management, Johnson & Johnson Pte Ltd, Singapore
Alfred Scheidegger, Partner And Founder, Nextech Invest, Switzerland
Andreas Schmidt, Chief Executive Officer, Proteona, Singapore
Toru Seo, APAC Head, S&E, Worldwide Business Development, Chief Business Officer, Pfizer, Japan
Hoon Seong, Deputy Manager, Genome & Company, Republic Of Korea
Jang Woo Shin, Senior Principal Scientist, Yuhan R&D Institute, Republic Of Korea
Eunho Shin, Medidata Solutions, Singapore
Hyejin Shin, Director, Group Leader, Clinical Qa, Samsung Bioepis, Republic Of Korea
Dwo Yuan Sia, Chief Technology Officer, BravoVax Co Ltd, China
Min Gyu Song, Head Researcher, Samchun, Republic Of Korea
Poh Loong Soong, Co-Founder, Ternion Biosciences Pte. Ltd, Singapore
Charles Stacey, President And Chief Executive Officer, Cerecin, Singapore
Haolin Sung, Director, Direct Investment, Diamond BioFund, Taiwan
Nadia Suttikulpanich, Head Of Fuchsia Innovation Center For Muang Thai Life Assurance, Muang Thai Life Assurance Public Company, Thailand
Kiyoshi Takayama, President, N.B. Health Laboratory Co Ltd, Japan
Jason Tamara Widjaja, Associate Director, Global Data Science (Ai And Data Products), msd, Singapore
Pei Yin Tan, Director, Asia Clinical Operations, Medicine Development Center, Eisai Clinical Research Singapore Pte Ltd, Singapore
Teck Jack Tan, Chairman And Medical Director, Northeast Medical Group, Singapore
I-Ning Tang, Senior Reviewer And Team Leader, Center For Drug Evaluation, Taiwan
Ken Taylor, Chief Executive Officer, Living Cell Technologies Limited, Australia
Gavin Teo, General Partner, B Capital Group, United States
Wenzhi Tian, Chief Executive Officer, ImmuneOnco Biopharma, China
Hsien-Hui Tong, Head, Venture Investing, SGInnovate, Singapore
Sophie Tsou, Associate Investigator, Division Of Biostatistics And Bioinformatics, National Health Research Institutes, Taiwan
Salah Uddin, Assistant Director, DGDA Bangladesh, Bangladesh
Marcel Van Duin, VP Research, Therapeutic Area Head, Reproductive Medicine & Women's Health, Ferring Pharmaceuticals, United States
Nilesh Wadhwa, Director, New Ventures and Transaction, Singapore, India Southeast Asia, Johnson & Johnson, Singapore
Judith Walker, Chief Medical Officer, Cerecin, Singapore
Gloria Wang, Chief Medical Officer, Shanghai Sinobioway Sunterra Biotech, China
Hwee-Lin Wee, President, Singapore Chapter, International Society for Pharmacoeconomics and Outcomes Research ISPOR, Singapore
Jeff Weisel, Director, Life Sciences & Healthcare Transaction Advisory, EY, Singapore
Susanne Weissbaecker, Global Head Of Access To Medicines, Takeda, Singapore
Kum Cheun Wong, Head Asia Pacific Policy And Liaison, Drug Regulatory Affairs, Novartis Asia Pacific, Singapore
Fiona Wong, Team Leader Clinical Studies Aspac, Danone Nutricia Research, Singapore
Dong-Hun Woo, COO/CTO, Nexel, Republic Of Korea
Jeffry Wu, Managing Director, Milestone Capital Management Ltd., China
Donald Xu, Managing Director, Lynx Financial, China
Teng Yan Yau, Chief Medical Officer, Holmusk, Singapore
Jing Ping Yeo, Director, Research Integrity, Compliance, Ethics, Singapore Health Services (SingHealth), Singapore
Ronghua Zhao, Chief Medical Officer, Virogin Biotech, Canada
